<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>LUTS in Men – Quick Reference</title>
<style>
    :root {
        --bg: #f4f7fa;
        --card: #ffffff;
        --primary: #005eb8;
        --warn: #d5281b;
        --accent: #00a499;
        --text: #212b32;
        --muted: #4c6272;
        --radius: 12px;
        --shadow: 0 4px 12px rgba(0,0,0,.08);
        --font: "Segoe UI", Roboto, Helvetica, Arial, sans-serif;
    }
    *{box-sizing:border-box;margin:0;padding:0}
    body{
        font-family:var(--font);
        background:var(--bg);
        color:var(--text);
        line-height:1.45;
        padding:20px;
    }
    .container{
        max-width:1000px;
        margin:auto;
    }
    h1{
        font-size:26px;
        margin-bottom:18px;
        color:var(--primary);
        text-align:center;
    }
    .card{
        background:var(--card);
        border-radius:var(--radius);
        box-shadow:var(--shadow);
        padding:20px;
        margin-bottom:22px;
    }
    .card h2{
        font-size:19px;
        margin-bottom:10px;
        color:var(--primary);
        border-bottom:1px solid #e1e8ed;
        padding-bottom:6px;
    }
    table{width:100%;border-collapse:collapse}
    th,td{padding:8px 10px;text-align:left;font-size:14px}
    th{background:#eef2f5;color:var(--muted);font-weight:600}
    tr:nth-child(even){background:#fafbfc}
    .tag{
        display:inline-block;
        font-size:12px;
        padding:2px 8px;
        border-radius:20px;
        color:#fff;
        background:var(--accent);
        margin-right:4px
    }
    .warn{background:var(--warn)}
    .pill-grid{
        display:grid;
        grid-template-columns:repeat(auto-fit,minmax(220px,1fr));
        gap:12px;
    }
    .pill{
        background:#eef2f5;
        padding:10px 14px;
        border-radius:var(--radius);
        font-size:14px;
    }
    .pill span{display:block;font-weight:600;color:var(--primary)}
    .flow{display:flex;flex-wrap:wrap;gap:10px;align-items:center;font-size:14px}
    .flow span{background:var(--primary);color:#fff;padding:6px 14px;border-radius:50px}
    .flow .arrow{color:var(--muted);font-size:20px}
</style>
</head>
<body>
<div class="container">
    <h1>LUTS in Men – Quick Reference Card</h1>

    <!-- Triage -->
    <div class="card">
        <h2>1. Triage & Red-Flags</h2>
        <table>
            <tr><th>Red-flag symptom/sign</th><th>Immediate action</th></tr>
            <tr><td>Visible haematuria, weight loss, hard/irregular prostate</td><td class="warn">2-week cancer referral</td></tr>
            <tr><td>Acute painful retention / palpable bladder</td><td class="warn">Admit & catheterise</td></tr>
            <tr><td>Bilateral sciatica, saddle numbness</td><td class="warn">Cauda equina – same-day MRI</td></tr>
            <tr><td>Fever, loin pain, positive dipstick</td><td>Treat infection (see UTI topic)</td></tr>
        </table>
    </div>

    <!-- Assessment -->
    <div class="card">
        <h2>2. 90-Second Assessment</h2>
        <ul style="font-size:14px;margin-left:18px">
            <li><strong>History:</strong> storage vs voiding vs dribble, bother score, meds, fluid/caffeine, ketamine</li>
            <li><strong>Exam:</strong> abdomen (bladder), DRE, external genitalia, focused neuro</li>
            <li><strong>Chart:</strong> 3-day frequency-volume chart if bothersome LUTS</li>
        </ul>
    </div>

    <!-- Investigations -->
    <div class="card">
        <h2>3. Bedside Investigations</h2>
        <div class="pill-grid">
            <div class="pill"><span>Urine dipstick</span>All patients</div>
            <div class="pill"><span>Creatinine / eGFR</span>If palpable bladder, nocturnal enuresis, recurrent UTI, stones</div>
            <div class="pill"><span>PSA discussion</span>Obstructive symptoms, abnormal DRE, patient concern</div>
        </div>
    </div>

    <!-- Management Algorithm -->
    <div class="card">
        <h2>4. Management Algorithm</h2>
        <div class="flow">
            <span>Red-flags excluded</span>
            <span class="arrow">→</span>
            <span>Bothersome LUTS?</span>
        </div>
        <br>
        <div style="display:flex;flex-wrap:wrap;gap:20px;font-size:14px">
            <div style="flex:1 1 220px">
                <strong>Voiding dominant</strong><br>
                Alpha-blocker <small>(Tamsulosin 400 µg nocte)</small><br>
                &nbsp;&nbsp;↓ if large prostate or PSA >1.4<br>
                Add 5-α-reductase inhibitor
            </div>
            <div style="flex:1 1 220px">
                <strong>Storage / OAB</strong><br>
                Lifestyle + bladder training<br>
                Antimuscarinic <small>(Oxybutynin 2.5 mg bd)</small><br>
                &nbsp;&nbsp;↓ if contra/not tolerated<br>
                Mirabegron 50 mg or Vibegron 75 mg
            </div>
            <div style="flex:1 1 220px">
                <strong>Nocturnal polyuria</strong><br>
                Late-afternoon Furosemide 20-40 mg<br>
                &nbsp;&nbsp;↓ if refractory<br>
                Desmopressin 50 µg SL (check Na⁺ day 3)
            </div>
            <div style="flex:1 1 220px">
                <strong>Post-micturition dribble</strong><br>
                Urethral milking technique ± pads
            </div>
        </div>
        <p style="margin-top:10px;font-size:14px"><strong>If inadequate control → refer urology</strong></p>
    </div>

    <!-- Drugs at a glance -->
    <div class="card">
        <h2>5. Drug Quick-Glance</h2>
        <table>
            <tr><th>Drug</th><th>Start dose</th><th>Key caution</th></tr>
            <tr><td>Tamsulosin</td><td>400 µg nocte</td><td>1st-dose hypotension, floppy iris</td></tr>
            <tr><td>Finasteride</td><td>5 mg od</td><td>↓ PSA 50 %, sexual SE, depression</td></tr>
            <tr><td>Oxybutynin</td><td>2.5 mg bd</td><td>Dry mouth, avoid if GFR < 30</td></tr>
            <tr><td>Mirabegron</td><td>50 mg od</td><td>Monitor BP; 25 mg if eGFR 30–59</td></tr>
            <tr><td>Vibegron</td><td>75 mg od</td><td>Monitor retention, ↑ digoxin</td></tr>
            <tr><td>Desmopressin</td><td>50 µg SL nocte</td><td>Fluid restrict 1 h pre-8 h post; Na⁺ day 3</td></tr>
        </table>
    </div>

    <!-- Refer & Resources -->
    <div class="card">
        <h2>6. Refer & Patient Resources</h2>
        <ul style="font-size:14px;margin-left:18px">
            <li><strong>Refer urology:</strong> failed drugs ≥ 3 m, complications (UTI, retention, renal impairment), suspected cancer/neuro cause.</li>
            <li><strong>NHS info:</strong> <a href="https://www.nhs.uk/conditions/prostate-enlargement/" target="_blank">Prostate enlargement</a></li>
            <li><strong>Bladder & Bowel Community:</strong> <a href="https://www.bladderandbowel.org" target="_blank">bladderandbowel.org</a> | 0161 214 4591</li>
        </ul>
   